Vedolizumab for the treatment of Crohn’s disease
Sign Up to like & getrecommendations! Published in 2018 at "Expert Review of Clinical Immunology"
DOI: 10.1080/1744666x.2018.1438189
Abstract: ABSTRACT Introduction: Crohn’s disease (CD) is an immune-mediated condition characterized by inflammation of the gut tissue, associated with progressive damage of the affected intestinal tract and possible complications. A treat-to-target approach is strongly advocated, consisting… read more here.
Keywords: treatment crohn; vedolizumab treatment; crohn disease;
Vedolizumab for the Treatment of Refractory Severe Rejection in Intestinal Transplantation
Sign Up to like & getrecommendations! Published in 2017 at "Transplantation"
DOI: 10.1097/01.tp.0000521364.18534.8f
Abstract: Introduction: Acute cellular rejection (ACR) is a continuous challenge in intestinal transplantation despite the advent of potent immunosuppressive drugs. Most of the traditional drugs used to treat ACR destroy specific cell lines with important systemic… read more here.
Keywords: intestinal transplantation; severe rejection; transplantation; vedolizumab treatment ... See more keywords
Effectiveness of vedolizumab treatment in two different anti-tumor necrosis factor alpha refractory pouchitis: A case report
Sign Up to like & getrecommendations! Published in 2019 at "World Journal of Clinical Cases"
DOI: 10.12998/wjcc.v7.i16.2316
Abstract: BACKGROUND Refractory pouchitis is a common cause of pouch failure, which may require surgical excision of the pouch or permanent diversion. We aimed to show the effect of vedolizumab on treatment of the patient with… read more here.
Keywords: refractory pouchitis; pouchitis case; anti tumor; vedolizumab treatment ... See more keywords